Ethicon Sarl v Gill [2021] FCAFC 29

Ethicon Sarl v Gill [2021] FCAFC 29

The appeal was dismissed because the manufacturers' devices were found to be defective within the meaning of the Trade Practices Act 1974 (Cth) and the Australian Consumer Law, due to the significant, clinically significant risks posed, combined with inadequate warnings, misleading information, and marketing. The manufacturers breached their duty of care in failing to conduct adequate testing, post-market surveillance, and to provide necessary warnings. The information provided did not equip medical practitioners or consumers to make adequately informed decisions, and the knowledge of surgeons at the time did not include the relevant complications. The causation, limitation, and...

Jurisdiction
Australia
Judgment Date
05 March 2021
Procedural Posture
Appeal / Full Court Appeal After Initial Trial With Orders
Outcome
Appeal dismissed, subject to variation to refine the form of one common-question order; original findings otherwise affirmed
Legal Topics
['defective Goods' 'medical Devices Regulation' 'misleading or Deceptive Conduct' 'duty to Warn' 'injunctions' 'limitation of Actions' 'class Actions']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Appeal / Full Court Appeal After Initial Trial With Orders

  1. 1 ['Whether the Ethicon medical devices were defective under the Trade Practices Act and Australian Consumer Law' 'Whether manufacturers failed to provide adequate warnings regarding risks' 'Whether there was misleading or deceptive conduct in marketing and instructions' 'Whether the manufacturers breached duty of care in negligence' 'Whether claims were statute-barred under limitation statutes' 'Appropriateness of grant of injunctive relief']

Ratio Decidendi

The appeal was dismissed because the manufacturers' devices were found to be defective within the meaning of the Trade Practices Act 1974 (Cth) and the Australian Consumer Law, due to the significant, clinically significant risks posed, combined with inadequate warnings, misleading information, and marketing. The manufacturers breached their duty of care in failing to conduct adequate testing, post-market surveillance, and to provide necessary warnings. The information provided did not equip medical practitioners or consumers to make adequately informed decisions, and the knowledge of surgeons at the time did not include the relevant complications. The causation, limitation, and...

Court Disposition

Appeal dismissed, subject to variation to refine the form of one common-question order; original findings otherwise affirmed

Orders

  • ['Subject to order 2, the appeal be dismissed.' 'By 4pm on 19 March 2021 the parties provide: (a) any competing submissions as to the costs of the appeal; (b) an agreed or competing form of order addressing the issue referred to in [812] to [818] of the reasons of the Full Court (s 33ZB order); and (c) any...